Kyoto University Life Science Showcase 2020, San Diego
Date and time
Location
Roth Auditorium at Sanford Consortium for Regenerative Medicine
2880 Torrey Pines Scenic Drive
La Jolla, CA 92037
KULS2020 - A showcase event introducing KYOTO biotech startups
About this event
In this event, we will introduce biotech startups with novel technologies and seeds from Kyoto University, Japan. We aim to connect US investors to Japanese academia-oriented startup companies. This will be an excellent opportunity to discover promising startups still in their early stages.
The technologies and seeds in the following fields:
- Pharmaceuticals
- Diagnostics
- Regenerative medicine
- Medical devices
The event schedule:
- 9:00 am Registration
- 9:30 am Opening remark
- 9:50 am Showcase (15min presentation and 25min discussion/each)
- 12:00 pm Lunch
- 1:00 pm Showcase (15min presentation and 25min discussion/each)
- 3:10 pm Reception (Networking)
- 5:00 pm Adjourn
For details, ask at kurcsd@mail2.adm.kyoto-u.ac.jp.
Presenting companies:
9:50-10:30
- Department of Drug Discovery for Lung Diseases, Kyoto University - Innovate the drug discovery for respiratory diseases using iPS-cell technology
10:30-11:10
- Therabiopharma - Development of curcumin monoglucuronide (CMG) as an anticancer drug for phase I/II clinical trials of refractory and rare cancers, glioblastoma and drug-resistant multiple myeloma
11:20-12:00
- Cyfuse Biomedical - Creation of functional tissue with a novel scaffold-free bio 3D printing technology
13:00-13:40
- Quadlytics - Offering epilepsy patients world's first clinically approved seizure prediction software
13:40-14:20
- Oligogen - Development of drug and cell therapy products using novel human neural stem cells “OligoGenie”
14:30-15:10
- KinoPharma - Innovative therapeutic drug development for cervical intraepithelial neoplasia (CIN) through industry-university collaboration
Commentators:
- Susie Harborth (COO, BioLabs; COO/CFO, Mission BioCapital)
- Jay Kunin, PhD (Boards of PharmaSecure, Inc. and Sironis, Inc.)
- Daria Mochly-Rosen, PhD (Professor of Chemical and Systems Biology at the Stanford University, Stanford SPARK)
- Charles E Prussak, PhD (Director of the Cell Therapy Translational Laboratory (CTTL), UCSD)
- Lada Rasochova, PhD, MBA (Executive Director, California Institute for Innovation and Development (CIID), Rady School of Management, UCSD)
Cosponsored by
Supported by
- Japan Agency for Medical Research and Development (AMED)
- Foundation for Biomedical Research and Innovation at Kobe (FBRI)
- Japan External Trade Organization (JETRO)
- Japan Forum for Innovation and Technology, UCSD (JFIT)
- Japan Science and Technology Agency (JST)
- Science and Innovation for the Next Generation (SING)